ABT
Abbott Laboratories
Stock
$96.69−2.14 (−2.17%)Close Oct 1, 2026
| Shareholders' equity (Q2 2026) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $51.1B | +1.1% | 9.7% | 9.4% |
| Shareholders' equity (Q2 2026) | $51.1B |
|---|---|
| YoY | +1.1% |
| 5-year CAGR | 9.7% |
| 10-year CAGR | 9.4% |
Shareholders' equity
| Period | Equity | YoY |
|---|---|---|
| 2025 | $52.1B | +9.4% |
| 2024 | $47.7B | +23.5% |
| 2023 | $38.6B | +5.2% |
| 2022 | $36.7B | +2.5% |
| 2021 | $35.8B | +9.2% |
| 2020 | $32.8B | +5.5% |
| 2019 | $31.1B | +1.8% |
| 2018 | $30.5B | −1.2% |
| 2017 | $30.9B | +50.4% |
| 2016 | $20.5B | −3.2% |
| 2015 | $21.2B | −1.5% |
| 2014 | $21.5B | −14.5% |
| 2013 | $25.2B | −5.8% |
| 2012 | $26.7B | +9.3% |
| 2011 | $24.4B | +7.8% |
| 2010 | $22.7B | −2.0% |
| 2009 | $23.1B | +32.4% |
| 2008 | $17.5B | −1.7% |
| 2007 | $17.8B | — |